CARLSBAD, Calif., April 3, 2017 /PRNewswire/ -- Natural Alternatives International, Inc. ("NAI") (NASDAQ: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, announced today that the U.S. Patent and Trademark Office has issued a Notice of Allowance of a patent application directed to a broad range of improved methods of beta-alanine intake.  These 28 allowed patent claims target such benefits as delaying muscle fatigue, increasing anaerobic capacity, increasing muscle strength and increasing muscle endurance. This patent when issued will not only become part of NAI's extensive global portfolio covering its CarnoSyn^® beta-alanine and SR CarnoSyn^® product, but more importantly, significantly lengthens the patent coverage around its original CarnoSyn^® beta-alanine to 2023.  Following this Notice of Allowance NAI intends to seek a significant number of additional patent claims to further broaden its intellectual property protection.

Mark A. LeDoux, NAI's CEO and Chairman of the Board, said that "NAI is very excited by the addition of this important intellectual property related to a broad range of improved methods of beta-alanine intake.  We believe this new patent continues to strengthen our worldwide portfolio of intellectual property related to our branded CarnoSyn^® beta-alanine.  Moreover, these patent rights will not expire until 2023, which gives NAI and its dedicated licensees the benefit of offering products that include CarnoSyn^® beta-alanine and the patent portfolio surrounding it.  These new patent rights further demonstrate our commitment and significant investment in the CarnoSyn^® beta-alanine business."

NAI, headquartered in Carlsbad, California, is a leading formulator, manufacturer and marketer of nutritional supplements and provides strategic partnering services to its customers. NAI's comprehensive partnership approach offers a wide range of innovative nutritional products and services to NAI's clients including: scientific research, clinical studies, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management and support, packaging and delivery system design, regulatory review and international product registration assistance. For more information about NAI, please see its website at http://www.nai-online.com.

This press release contains forward-looking statements within the meaning of applicable securities laws that are not historical facts and information. These statements represent our intentions, expectations and beliefs concerning future events, including, among other things, our expectations and beliefs with respect to our intellectual property rights and the potential expansion thereof, the outcome of pending litigation, the continued validity of our patents, and our ability to successfully develop, license and enforce our intellectual property rights. We wish to caution readers these statements involve risks and uncertainties that could cause actual results and outcomes for future periods to differ materially from any forward-looking statement or views expressed herein. NAI's financial performance and the forward-looking statements contained herein are further qualified by other risks including those set forth from time to time in the documents filed by us with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q.

CONTACT – Kenneth Wolf, President and Chief Operating Officer, Natural Alternatives International, Inc., at 760-736-7700 or investor@nai-online.com.

Web site: http://www.nai-online.com/

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/natural-alternatives-international-inc-announces-extension-of-carnosyn-beta-alanine-intellectual-property-portfolio-300432972.html

SOURCE Natural Alternatives International, Inc.